Delivery Order SPE2DB24D1104-SPE2DB25FXWU6

Award Date 1/23/25
Potential Completion Date 1/24/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4565683377 - HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $1,436.80. The contract is not set aside and has an ultimate completion date of September 5, 2024. AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, is the prime contractor for this award. The contract is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.96 firm fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has an ultimate completion date of May 8, 2023 and was awarded on May 5, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,366.20 Firm Fixed Price contract is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a diabetes medication. This is a Delivery Order issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,540.14 and is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a type of insulin medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 27, 2024. The contract was awarded on December 26, 2024 and does not have a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed price agreement with a ceiling value of $1,422.96 and runs through August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support military treatment facilities and other federal healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a specific pharmaceutical product - Humalog 100 unit/mL vial 10 mL. The contract is a firm-fixed-price delivery order with a ceiling value of $1,147.77 and an ultimate completion date of January 22, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The potential value of the award is $1,010.71 and the period of performance runs through February 13, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp holds a larger indefinite...
This federal contract award, valued at $1,092.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 3, 2024. There is no set-aside designation for this award. Amerisourcebergen holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract, valued at $1,639.44, is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a prescription insulin medication. The contract has an ultimate completion date of May 17, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humalog 100 Unit/mL insulin vials, with a ceiling value of $2,732.40 and a completion date of January 20, 2023. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FXWU6
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a diabetes medication, and has a firm fixed price of $1,413.30 with a ceiling value of $1,413.30. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have any set-aside designation, indicating open competition.

Generated 4/24/25, 11:10 AM